Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Quincy, IL
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Quincy, IL
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Evansville, IN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
New Albany, IN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Westwood, KA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Westwood, KA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Wichita, KA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Louisville, KY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Columbia, MD
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Columbia, MD
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Fairhaven, MA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Fairhaven, MA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
St Louis, MO
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Bronx, NY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
New York, NY
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Charleston, SC
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Memphis, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Bedford, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Longview, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Longview, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Odessa, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Odessa, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
San Marcos, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
San Marcos, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Sherman, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Sherman, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Sugar Land, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
The Woodlands, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Wichita Falls, TX
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Burlington, VT
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Spokane, WA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Vancouver, WA
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Morgantown, WV
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Madison, WI
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated:  10/22/2015
mi
from
Buenos Aires,
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
Status: Enrolling
Updated: 10/22/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase II Study to Evaluate the Efficacy and Toxicity of Multimodality Treatment With Induction Taxotere/Cisplatin?5-FU (TPF) Chemotherapy Followed by Concomitant Cetuximab and Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase II Study to Evaluate the Efficacy and Toxicity of Multimodality Treatment With Induction Taxotere/Cisplatin?5-FU (TPF) Chemotherapy Followed by Concomitant Cetuximab and Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
A Limited, First-in-Man, Phase IB Evaluation of BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With High-Volume Osseous Metastases and no Standard Treatment Options
Status: Enrolling
Updated:  10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
A Limited, First-in-Man, Phase IB Evaluation of BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With High-Volume Osseous Metastases and no Standard Treatment Options
Status: Enrolling
Updated: 10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated:  10/22/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated: 10/22/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery
Effect of Intensive Education on Breast Cancer Patient's Understanding of Lymphedema
Status: Enrolling
Updated:  10/22/2015
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery
Effect of Intensive Education on Breast Cancer Patient's Understanding of Lymphedema
Status: Enrolling
Updated: 10/22/2015
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
Status: Enrolling
Updated:  10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
Status: Enrolling
Updated: 10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
The Mayo Clinic
mi
from
Rochester, MN
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
A Phase II Trial of a Chemotherapy Based Regimen of Intravenous Busulfan (Busulfex), Melphalan and Thiotepa as Myeloablative Regimen Followed by a T- Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant From and HLA-Compatible Donor in the Treatment of High Risk Ewing's Sarcoma Family Tumors
Status: Enrolling
Updated:  10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
A Phase II Trial of a Chemotherapy Based Regimen of Intravenous Busulfan (Busulfex), Melphalan and Thiotepa as Myeloablative Regimen Followed by a T- Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant From and HLA-Compatible Donor in the Treatment of High Risk Ewing's Sarcoma Family Tumors
Status: Enrolling
Updated: 10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Phase II Trial of Cetuximab Plus Cisplatin and Irinotecan in Patients With Irinotecan and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated:  10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Phase II Trial of Cetuximab Plus Cisplatin and Irinotecan in Patients With Irinotecan and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Status: Enrolling
Updated: 10/22/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Phase 2 Study of 153 Sm-EDTMP Followed by Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Status: Enrolling
Updated:  10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Phase 2 Study of 153 Sm-EDTMP Followed by Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Status: Enrolling
Updated: 10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Metabolic Genotypes and Oncogenic Damage in Breast Cancer
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Metabolic Genotypes and Oncogenic Damage in Breast Cancer
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Providence Cancer Center
mi
from
Anchorage, AK
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Providence Cancer Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
mi
from
Ft. Smith, AR
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
mi
from
Ft. Smith, AR
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
mi
from
Burbank, CA
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated:  10/23/2015
Cancer Care Center at John Muir Health - Concord Campus
mi
from
Concord, CA
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Status: Enrolling
Updated: 10/23/2015
Cancer Care Center at John Muir Health - Concord Campus
mi
from
Concord, CA
Click here to add this to my saved trials